While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Barely able to run around the block four years ago, the Connecticut native took up running to keep up with her two kids and ...

Shares of Lexicon Pharmaceuticals LXRX have jumped 30% after signing a licensing deal for its pre-clinical obesity drug LX9851 with pharma giant Novo Nordisk NVO last week. Per the deal terms, Lexicon ...

Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...

A review and analysis of reams of earlier research found that being out of shape doubled or tripled the risk of dying ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the health care system is improving.

Policymakers should focus on both obesity prevention and better access to treatment for those already living with obesity.

From growth charts to anemia thresholds, clinical standards assume a single human prototype. Why are we still using ...

Copyright 2025 The Associated Press. All Rights Reserved. Illinois Gov. JB Pritzker listens to David Richardson, right, associate vice chancellor for research, during ...

A new study suggests that following a healthy plant-based diet may help individuals with cardiometabolic conditions—such as obesity, diabetes, and heart disease—live longer. Researchers ...

Billboard’s Top Women Artists of the 21st Century chart reflects performance on weekly charts dated Jan. 1, 2000, through Dec. 28, 2024. (Titles released prior to mid-1999, including holiday ...

Market sentiment charts show selling pressure subsiding, but panic could trigger a bullish turn. The stock market's constant reaction to policy uncertainty and tariffs has dominated the news over ...